AnteoTech has announced that its EuGeni Reader and accompanying COVID-19 Antigen Rapid Test (ART) have received CE mark registration as the company looks to progress with European distribution. Share this:FacebookXLike this:Like Loading... You May Also Like Healthcare Technology 12-11-2020 Fitch: COVID-19 accelerating insurers’ financial headwinds Healthcare Technology 03-05-2022 Divurgent Appoints Ed Marx as New CEO Healthcare Technology 05-10-2021 Interview for analytic developer 1 position Healthcare Technology 18-10-2021 Power supply to support heat dissipation allows up to 1000W